Shengyan Hong

Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma

Wolfgang Wick, Vinay K. Puduvalli, Marc C. Chamberlain et al. · Journal of Clinical Oncology · 2010 · 514 citations

Medicine, Oncology, Pharmacotherapy +16

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · JAMA Oncology · 2021 · 349 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural Mesothelioma

Jacek Jassem, Rodryg Ramlau, Armando Santoro et al. · Journal of Clinical Oncology · 2008 · 231 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

Mark A. Socinski, Egbert F. Smit, Paul Lorigan et al. · Journal of Clinical Oncology · 2009 · 215 citations · Full text

Medicine, Oncology, Pharmacology +12

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · Journal of Clinical Oncology · 2022 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +17